Motus Gi Holdings, Inc. MOTS
We take great care to ensure that the data presented and summarized in this overview for Motus GI Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MOTS
Top Purchases
Top Sells
About MOTS
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Insider Transactions at MOTS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2022
|
Timothy P. Moran Director |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+21.02%
|
-
|
|
Feb 10
2022
|
Mark Pomeranz President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+26.77%
|
-
|
|
Feb 10
2022
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+29.17%
|
-
|
|
Jan 05
2022
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
90,521
+31.75%
|
-
|
|
Jan 05
2022
|
Sonja Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+45.03%
|
-
|
|
Jan 05
2022
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
127,083
+30.35%
|
-
|
|
Jan 05
2022
|
Gary J Pruden Director |
BUY
Grant, award, or other acquisition
|
Direct |
106,563
+28.83%
|
-
|
|
Jan 05
2022
|
Shervin J Korangy Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+30.25%
|
-
|
|
Nov 19
2021
|
Timothy P. Moran Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.03%
|
$0
$0.52 P/Share
|
|
Nov 19
2021
|
Mark Pomeranz President and COO |
BUY
Open market or private purchase
|
Direct |
4,000
+2.37%
|
$0
$0.51 P/Share
|
|
Nov 19
2021
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+1.45%
|
$0
$0.51 P/Share
|
|
Jun 22
2021
|
Sonja Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,209
+50.0%
|
-
|
|
Feb 17
2021
|
Andrew Lawrence Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+30.98%
|
-
|
|
Feb 17
2021
|
Shervin J Korangy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,225
+20.68%
|
-
|
|
Feb 17
2021
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,472
+19.86%
|
-
|
|
Feb 17
2021
|
Timothy P. Moran Director |
BUY
Grant, award, or other acquisition
|
Direct |
141,000
+22.98%
|
-
|
|
Feb 17
2021
|
Mark Pomeranz President and COO |
BUY
Open market or private purchase
|
Direct |
65,000
+28.78%
|
-
|
|
Feb 17
2021
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
52,191
+22.19%
|
-
|
|
Feb 17
2021
|
Gary J Pruden Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,124
+16.5%
|
-
|
|
Feb 17
2021
|
Samuel R Md Nussbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,225
+22.53%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders